Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Farmaceutical Rx (Frx) has shown varied performance across different product categories in Ohio. Notably, in the Concentrates category, the brand made a significant entry into the top 30 rankings in November 2024, securing the 24th position. This suggests a positive trend and increasing consumer interest in their concentrate products. However, in the Edible category, the brand's ranking dropped from 38th in August to 51st in November, indicating a potential challenge in maintaining its position in this competitive segment. Such fluctuations highlight the importance of strategic adjustments to capture and sustain market share in the edibles space.
In the Flower category, Farmaceutical Rx (Frx) displayed a relatively stable performance, maintaining a consistent presence around the mid-30s in rankings. This stability could be seen as a steady demand for their flower products, despite a slight dip in sales during the observed months. On the other hand, the Vapor Pens category has been a success story for the brand, with a remarkable climb from 44th place in August to 26th by November. This upward trajectory indicates a robust growth in consumer preference for their vapor pen offerings, potentially driven by quality or innovation in their product line. Such performance insights are crucial for understanding the brand's market dynamics and potential areas for growth or improvement.
Competitive Landscape
In the competitive landscape of the flower category in Ohio, Farmaceutical Rx (Frx) has experienced fluctuating rankings over the past few months, indicating a dynamic market presence. Notably, Farmaceutical Rx (Frx) maintained a relatively stable position, ranking 35th in both August and November 2024, despite a dip to 39th in September. This stability is contrasted with competitors like Firelands Scientific, which improved from 38th in August to 34th in November, and Matter., which saw a decline from 32nd in August to 39th in November. Meanwhile, Moxie experienced a significant drop from 19th in August to 38th in November, highlighting potential challenges in maintaining market share. Curaleaf showed some volatility as well, with rankings fluctuating between 29th and 42nd. These shifts suggest that while Farmaceutical Rx (Frx) faces stiff competition, its ability to maintain a consistent rank amidst these changes could be a strategic advantage in the Ohio flower market.
Notable Products
In November 2024, the top-performing product for Farmaceutical Rx (Frx) was the OG Strawberry Distillate Cartridge (0.5g) within the Vapor Pens category, which climbed to the first rank with sales of 625 units. The Orange Dream Distillate Cartridge (1g) followed closely in second place, marking its debut in the rankings for the year. Another notable entry in the Vapor Pens category was the Tropical Trainwreck Distillate Cartridge (0.5g), securing the third position. The Milkbone (2.83g) from the Flower category saw a rise to fourth place, showing a steady increase from its previous second-place ranking in October. Meanwhile, GMO (2.83g), which consistently held the top spot from August to October, dropped to fifth place, indicating a significant shift in consumer preference.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.